Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients.

Saved in:
Bibliographic Details
Title: Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients.
Authors: Khairallah P; Section of Nephrology, Baylor College of Medicine, Houston, Texas, USA., Robbins-Juarez S; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA., Patel S; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., Shah V; Department of Medicine, SUNY University at Buffalo, Buffalo, New York, USA., Toma K; Jersey Coast Nephrology and Hypertension Associates, Brick, New Jersey, USA., Fernandez H; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., Dube GK; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., King K; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., Mohan S; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., Husain SA; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., Morris H; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA., Crew RJ; Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Source: Clinical transplantation [Clin Transplant] 2023 Jan; Vol. 37 (1), pp. e14853. Date of Electronic Publication: 2022 Dec 07.
Publication Type: Journal Article
Journal Info: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 8710240 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-0012 (Electronic) Linking ISSN: 09020063 NLM ISO Abbreviation: Clin Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1399-0012
DOI:10.1111/ctr.14853